Long-term clinical outcomes after upgrade to resynchronization therapy: A propensity score–matched analysis

Background: Upgrade to cardiac resynchronization therapy (CRT) is common in Europe, despite little and conflicting evidence. Objective: To compare long-term clinical outcomes in a cohort of patients receiving de novo or upgrade to CRT. Methods: Single-center retrospective study of 295 consecutive pa...

Full description

Bibliographic Details
Main Authors:	Mariana Brandão, MD, MSc, João Gonçalves Almeida, MD, MSc, Paulo Fonseca, MD, MSc, Joel Monteiro, MD, MSc, Elisabeth Santos, MSc, Filipa Rosas, MSc, José Nogueira Ribeiro, MSc, Marco Oliveira, MD, MSc, Helena Gonçalves, MD, MSc, João Primo, MD, MSc, Ricardo Fontes-Carvalho, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2021-12-01
Series:	Heart Rhythm O2
Subjects:	Cardiac resynchronization therapy Upgrade Heart failure Pacemaker Implantable cardioverter-defibrillator
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666501821001574

Similar Items

Triple atrial sensing during cardiac resynchronization
by: S. Serge Barold, et al.
Published: (2020-02-01)

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis
by: Kilian Fischer, et al.
Published: (2022-02-01)

Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort
by: Niraj Varma, et al.
Published: (2017-05-01)

Unusual fracture in a Durata lead with shock coil fragmentation and cable externalization
by: Toshiaki Sato, MD, et al.
Published: (2017-07-01)

Quality of life of patients with implanted devices for permanent cardiac pacing assessed with the SF-36v2 Health Survey
by: Izabela Wojarska, et al.
Published: (2021-05-01)

Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure
by: Christine I. Nichols, et al.
Published: (2016-02-01)

Identification and management of right ventricular perforation using pacemaker and cardioverter-defibrillator leads: A case series and mini review
by: Mohammad Ali Akbarzadeh, MD, et al.
Published: (2017-02-01)

Aortic perforation due to cardiac resynchronisation therapy defibrillator lead placement: Case report and medicolegal considerations
by: Antonino M. Grande, MD, et al.
Published: (2015-12-01)

Reuse Potential of Pacemakers and Implantable Cardioverter-defibrillators - Some Real World Data
by: S.P. Abhilash, et al.
Published: (2013-05-01)

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device
by: Michele Murphy, MD, et al.
Published: (2016-11-01)

Secondary prevention of sudden cardiac death
by: Neal A. Chatterjee, MD, MSc, et al.
Published: (2020-10-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

Beneficial Effects of Upgrading from Right Ventricular Pacing to Cardiac Resynchronization Therapy in Patients with Heart Failure Compared to de Novo Cardiac Resynchronization Therapy
by: Tomoyuki Kabutoya, MD, et al.
Published: (2010-01-01)

Sex‐Specific Differences in Survival and Heart Failure Hospitalization After Cardiac Resynchronization Therapy With or Without Defibrillation
by: Francisco Leyva, et al.
Published: (2019-11-01)

The Relationship between Optimization for Cardiac Resynchronization Therapy by Measurement of dp/dt and the Middle-to-long-term Prognosis of Heart Failure Patients
by: Tomoyuki Kabutoya, MD, et al.
Published: (2011-01-01)

Current status of implantable defibrillator devices in patients with left ventricular dysfunction — The first report from the online registry database
by: Akihiko Shimizu, MD, et al.
Published: (2008-01-01)

Cardiac implantable electronic devices in Bulgaria: results from the electronic registry BG-Pace for 2022
by: V. Traykov, et al.
Published: (2023-12-01)

Innovative Cardiac Resynchronization
by: Zaki Akhtar, MBBS, et al.
Published: (2021-04-01)

Variation in Lead Impedance according to Pacemaker Analyzing Systems
by: Hiroshi Ichiyanagi, et al.
Published: (2010-01-01)

Cardiac Resynchronization Therapy in a Chagasic Patient With Persistent Left Superior Vena Cava
by: Lucas Hollanda, MD, MSc, et al.
Published: (2019-10-01)

Right ventricular lead proarrhythmia: A novel intervention for an under-recognized phenomenon
by: Justin Hayase, MD, et al.
Published: (2018-02-01)

Unregulated online sales of cardiac implantable electronic devices in the United States: A six-month assessment
by: Bolanle Akinyele, MD, et al.
Published: (2020-10-01)

Implantation of a Resynchronization Implantable Cardioverter Defibrillator in a Patient with Persistent Left Superior Vena Cava
by: Dante Antonelli, et al.
Published: (2007-10-01)

Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis
by: Jayasree Pillarisetti, MD, et al.
Published: (2015-01-01)

Hybrid subcutaneous and transvenous approach for cardiac resynchronization defibrillator implant in a patient with congenital heart disease and tricuspid bioprosthetic
by: Pooneh Nabavizadeh, MD, et al.
Published: (2020-01-01)

Radiofrequency ablation–assisted extraction of a pacing lead fragment
by: J. William Schleifer, MD, et al.
Published: (2015-07-01)

Lead management in setting of limited venous accesses: A case report and review of literature
by: Mohsin Khan, MD, et al.
Published: (2021-08-01)

Anticoagulant therapy during cardiovascular implantable electronic device procedures
by: Aurelija Daubaraitė, et al.
Published: (2023-06-01)

Impact of raising the upper extremity siding cardiac implantable electrical devices on postoperative safety
by: Tomonori Takeda, et al.
Published: (2023-08-01)

Isolated right ventricular failure and abnormal hemodynamics caused by right ventricular pacing are reversed with cardiac resynchronization therapy
by: Milena A. Gebska, MD, PhD, et al.
Published: (2015-07-01)

Evaluating multisite pacing strategies in cardiac resynchronization therapy in the preclinical settingKey Findings
by: Luuk I.B. Heckman, MD, et al.
Published: (2020-06-01)

Obstacles preventing biventricular pacing mitigated with lead extraction and His bundle pacing to achieve effective cardiac resynchronization
by: Advay G. Bhatt, MD, FHRS, et al.
Published: (2017-11-01)

Cardiac Resynchronization Therapy: Who Benefits?
by: Jason S. Chinitz, et al.
Published: (2014-04-01)

Cardiac implantable electronic devices in Bulgaria: results from the electronic registry BG-Pace for the period 2019-2021
by: Vassil Traykov, et al.
Published: (2021-10-01)

Prevention of Cardiac Implantable Electronic Device Infections: A Review
by: Grzegorz Sławiński, et al.
Published: (2023-06-01)

Radiotherapy for patients with cardiovascular implantable electronic device-a single institutional experience
by: Bhargavi Ilangovan, et al.
Published: (2022-01-01)

Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey
by: John Fanourgiakis, et al.
Published: (2016-01-01)

Wire countertraction for sheath placement through stenotic and tortuous veins: The “body flossing” techniqueKey Findings
by: Jeffrey S. Arkles, MD, FHRS, et al.
Published: (2020-04-01)

Interventional challenges due to venous occlusion during cardiac resynchronization therapy in patients with prior cardioverter-defibrillator implantation: Case report
by: Veysel Kutay Vurgun, et al.
Published: (2016-07-01)